CORC  > 中南大学
Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
Ou, Yangyang; Zhai, Denggao; Wu, Nan; Li, Xiaoli*
刊名Gene
2015
卷号572期号:1页码:116-122
关键词HCC hepatocellular carcinoma HepG2-R cisplatin-resistant HepG2 3′-UTR 3′-Untranslated Regions MiRNAs microRNAs FBS fetal bovine serum RT reverse transcription NCO oligonucleotide MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide PI propidium iodide MiR-363 Mcl-1 HepG2-R Apoptosis Cisplatin
ISSN号0378-1119
DOI10.1016/j.gene.2015.07.002
URL标识查看原文
WOS记录号WOS:000361925900016
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3321126
专题中南大学
作者单位1.[Li, Xiaoli
2.Wu, Nan
3.Zhai, Denggao
4.Ou, Yangyang] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Ou, Yangyang,Zhai, Denggao,Wu, Nan,et al. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1[J]. Gene,2015,572(1):116-122.
APA Ou, Yangyang,Zhai, Denggao,Wu, Nan,&Li, Xiaoli*.(2015).Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.Gene,572(1),116-122.
MLA Ou, Yangyang,et al."Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1".Gene 572.1(2015):116-122.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace